| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/26/2011 | US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124692 Crystalline forms of thiazolidinedione compound and its manufacturing method |
| 05/26/2011 | US20110124678 Treatment with alpha 7-selective ligands |
| 05/26/2011 | US20110124674 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 05/26/2011 | US20110124652 Chemical Compounds and Uses |
| 05/26/2011 | US20110124648 Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/26/2011 | US20110124643 Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof |
| 05/26/2011 | US20110124641 Benzothiazole kinase inhibitors and methods of use |
| 05/26/2011 | US20110124637 Benzimidazoles and related analogs as sirtuin modulators |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124624 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124611 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 05/26/2011 | US20110124609 Method of Preventing Type I Diabetes |
| 05/26/2011 | US20110124608 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals |
| 05/26/2011 | US20110124587 Pure Rebaudioside A |
| 05/26/2011 | US20110124562 Apoaequorin-containing compositions and methods of using same |
| 05/26/2011 | US20110124559 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/26/2011 | US20110124557 Blood sugar-modulating polypeptides |
| 05/26/2011 | US20110124556 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 05/26/2011 | US20110124555 Use of somatostatin analogs in control of hypoglycemia |
| 05/26/2011 | US20110124554 Fibrosuppressant Biotherapeutics |
| 05/26/2011 | US20110124553 Insulin-oligomer conjugates, formulations and uses thereof |
| 05/26/2011 | US20110124552 GMCSF and Truncated CCL2 Conjugates and Methods and Uses Thereof |
| 05/26/2011 | US20110123654 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 05/26/2011 | US20110123651 Dietary supplement drink for delivery of resveratrol and other polyphenols |
| 05/26/2011 | US20110123648 Use of coconut water extract or coconut shell extract for treating immunological diseases and/or disorders |
| 05/26/2011 | US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123616 Calcium Carbonate Granulation |
| 05/26/2011 | US20110123609 Multiple unit dosage form of niacin |
| 05/26/2011 | US20110123599 Aroma therapy patch |
| 05/26/2011 | US20110123575 Modified release niacin formulations |
| 05/26/2011 | US20110123573 Methods and compositions for treating phenylketonuria |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123521 Methods for modulating expression of rbp4 |
| 05/26/2011 | US20110123517 Dissolvable pharmaceutical implant |
| 05/26/2011 | US20110123513 Alkaline phosphatase to reduce or prevent weight gain |
| 05/26/2011 | US20110123506 Dietary health food composition, package and method of use |
| 05/26/2011 | US20110123502 Method for obtaining treg-cells |
| 05/26/2011 | US20110123501 Gut flora and weight management |
| 05/26/2011 | US20110123481 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| 05/26/2011 | US20110123466 Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome c |
| 05/26/2011 | US20110123454 Method for modulating appetite |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | CA2781672A1 Polypeptide conjugate |
| 05/26/2011 | CA2781286A1 Oral formulation for dexlansoprazole |
| 05/25/2011 | EP2325300A1 Desaturase genes and uses thereof |
| 05/25/2011 | EP2325182A1 Bicyclic compounds and use as antidiabetics |
| 05/25/2011 | EP2325179A1 Glycosidase ihhibitors and preparation thereof |
| 05/25/2011 | EP2325169A2 Lisofylline analogues and their pharmeacuetical uses |
| 05/25/2011 | EP2324861A1 In vivo use of water absorbent polymers |
| 05/25/2011 | EP2324852A1 Therapeutic or prophylactic agent for generalized pain syndrome |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2324837A1 Synthetic lipophilic inositol glycans for treatment of glucose-metabolism disorders |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324832A1 Nutritional supplement while taking hormonal contraceptives |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2324826A1 Hydrophilic amino acid-containing preparation having improved taste |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324812A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 05/25/2011 | EP2324036A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 05/25/2011 | EP2324028A2 Therapeutic agents 414 |
| 05/25/2011 | EP2324017A2 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
| 05/25/2011 | EP2324015A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 05/25/2011 | EP2324005A1 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 05/25/2011 | EP2324002A2 Processes for the preparation of sglt2 inhibitors |
| 05/25/2011 | EP2323985A1 Tripyridyl carboxamide orexin receptor antagonists |
| 05/25/2011 | EP2323676A1 Protein based product from fenugreek seeds that regulates dyslipidemia and obesity, and a process for the preparation thereof |
| 05/25/2011 | EP2323669A1 Arabinoxylans for modulating the barrier function of the intestinal surface |
| 05/25/2011 | EP2323668A1 Use of d-ribose for fatigued subjects |
| 05/25/2011 | EP2323652A2 Treatment of lysosomal storage disorders and other proteostatic diseases |
| 05/25/2011 | EP2323650A1 Treatment for diabetes in patients inappropriate for metformin therapy |
| 05/25/2011 | EP2323649A2 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof |
| 05/25/2011 | EP1894576B1 Novel triglyceride reducing agent |
| 05/25/2011 | EP1470102B1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1786031B Glucagon kind polypeptide-1 analogue, its preparation method and application |
| 05/25/2011 | CN102076854A Rna antagonist compounds for inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtgpat1) |
| 05/25/2011 | CN102076704A Synthesis of timosaponin BII |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076672A Novel five-membered ring compound |
| 05/25/2011 | CN102076671A Triazole derivative or salt thereof |
| 05/25/2011 | CN102076670A Compounds and methods for modulating g protein-coupled receptors |
| 05/25/2011 | CN102076662A Alpha-mercapto-amides |
| 05/25/2011 | CN102076650A Carboxylic acid compound |
| 05/25/2011 | CN102076347A Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 05/25/2011 | CN102070756A Sugar-responsive medicament delivery material and preparation method thereof |
| 05/25/2011 | CN102070726A Method for safely extracting cordyceps sinensis polysaccharide |
| 05/25/2011 | CN102070717A Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070657A Bis-o-vanillin ethylene diamine schiff base and transitional metal coordination compound and preparation method thereof |
| 05/25/2011 | CN102068700A Phenylboronic acid polyethylene glycol gel and application thereof serving as glucose-sensitive material |
| 05/25/2011 | CN102068670A Chinese medicinal composition for treating hyperlipidemia |